Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
AI and Machine learning are transforming biomedical research at an astounding pace, enabling...
We are pleased to announce the launch of a new 2-day conference format for conferences on emerging...
As we wrap up our fall season, the community has taken to Twitter/X with rave reviews and...
In addition to covering emerging developments in vaccine science, design and technology, the ...
Keystone Symposia conferences hold a special place in science for their ability to drive...
2018 Nobel Laureate Dr. Jim Allison, and organizer of the 2024 Keystone Symposia on Cancer...
In addition to covering emerging developments in vaccine science, design and technology, the ...
Over the course of the last 50 years, Keystone Symposia has convened conferences that connect...
Welcome to the Keypoint Newsletter, bringing you all the latest news & views from Keystone...
In June, we held our long-awaited 50th Anniversary Gala (after being postponed by the pandemic),...
